Ascletis Pharma Inc. (HKG:1672)
Hong Kong · Delayed Price · Currency is HKD 15.20
-0.29 (-1.87%)
May 20, 2026, 11:14 AM HKT
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of 16.44 billion as of May 19, 2026. Its market cap has increased by 171.95% in one year.
Market Cap
16.44B
Enterprise Value
14.32B
Revenue
2.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.20
Market Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has increased from 15.69B to 16.44B, an increase of 4.76%. That is a compound annual growth rate of 0.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 16.44B | 46.23% |
| Dec 31, 2025 | 11.24B | 287.10% |
| Dec 31, 2024 | 2.90B | 90.74% |
| Dec 29, 2023 | 1.52B | -70.46% |
| Dec 30, 2022 | 5.15B | 44.13% |
| Dec 31, 2021 | 3.58B | 13.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 30.76B |
| InnoCare Pharma | 25.55B |
| Duality Biotherapeutics | 20.70B |
| TransThera Sciences (Nanjing) | 19.63B |
| Keymed Biosciences | 19.46B |
| Ascentage Pharma Group International | 14.46B |
| CStone Pharmaceuticals | 12.93B |
| Nanjing Leads Biolabs | 12.40B |